Israel Englander’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-232,027
Closed -$3.2M 5920
2026
Q1
$3.2M Buy
+232,027
New +$3.5M ﹤0.01% 3411
2025
Q4
Sell
-741,267
Closed -$13.7M 6057
2025
Q3
$13.7M Sell
741,267
-1,259,562
-63% -$19.8M 0.01% 2055
2025
Q2
$32M Buy
2,000,829
+1,476,359
+281% +$26.3M 0.02% 1135
2025
Q1
$10.2M Sell
524,470
-658,231
-56% -$13.9M 0.01% 2171
2024
Q4
$26.1M Sell
1,182,701
-298,527
-20% -$5.75M 0.01% 1312
2024
Q3
$24.9M Buy
1,481,228
+831,722
+128% +$12.3M 0.01% 1345
2024
Q2
$7.76M Sell
649,506
-636,322
-49% -$7.11M ﹤0.01% 2316
2024
Q1
$14.2M Sell
1,285,828
-522,007
-29% -$5.33M 0.01% 1851
2023
Q4
$15.7M Buy
1,807,835
+726,322
+67% +$5.65M 0.01% 1759
2023
Q3
$8.27M Buy
1,081,513
+796,687
+280% +$5.98M ﹤0.01% 2226
2023
Q2
$2.05M Buy
284,826
+163,888
+136% +$956K ﹤0.01% 3460
2023
Q1
$737K Buy
120,938
+109,758
+982% +$595K ﹤0.01% 4344
2022
Q4
$49K Sell
11,180
-2,423
-18% -$10.8K ﹤0.01% 5781
2022
Q3
$53K Buy
+13,603
New +$68.2K ﹤0.01% 6170

Other funds holding CLBT

Israel Englander's CLBT Position: Q2 2026 in Review

Israel Englander sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 232,027 shares — an estimated $3.2M sold.

Israel Englander first reported a position in CLBT in Q3 2022 and held it in 14 quarters. The position peaked at $32M in Q2 2025. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Israel Englander reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 232,027 Cellebrite shares in Q2 2026, an estimated $3.2M.
  • Israel Englander first reported a position in Cellebrite in Q3 2022 and held it in 14 quarters.
  • Israel Englander's Cellebrite position peaked at $32M in Q2 2025.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.